GlassScriptPhysician profile
Aaron B Grotas
NPI 1518092048
$5,418.73
in general payments reported to CMS, 2019-2025
44 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $264 · 2021: $562 · 2022: $730 · 2023: $913 · 2024: $1,333 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,203 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,202.91 |
| Education | $299.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $723.51 | 2019-2025 | Xtandi, Myrbetriq |
| Antares Pharma, INC. | $517.57 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $504.66 | 2019-2025 | Erleada |
| Endo USA, INC. | $401.84 | 2024-2025 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $297.32 | 2021-2025 | |
| Teleflex LLC | $228.66 | 2021-2023 | Urolift |
| Nevro Corp. | $180.30 | 2024 | Senza |
| Progenics Pharmaceuticals, INC. | $171.05 | 2023-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $167.75 | 2019-2024 | Xiaflex, Aveed, Edex |
| Blue Earth Diagnostics | $152.62 | 2020-2025 | Posluma |
| Hollister Incorporated | $149.79 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $136.78 | 2024-2025 | Trelstar |
| Ambu INC. | $133.49 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $129.85 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $128.22 | 2023-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $127.47 | 2019-2024 | Rezum Generator |
| Tolmar, INC. | $127.04 | 2023-2025 | Jatenzo |
| Pfizer INC. | $122.36 | 2021-2024 | |
| Halozyme INC | $103.42 | 2023 | |
| Becton, Dickinson and Company | $90.82 | 2025 | Bd Onclarity |
| Urovant Sciences INC | $75.60 | 2022 | |
| Urogen Pharma, INC. | $72.83 | 2024-2025 | |
| Myovant Sciences INC. | $68.52 | 2022 | |
| Calyxo, INC. | $50.67 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $48.81 | 2024 | Keytruda |
| Olympus America INC. | $48.50 | 2025 | Itind System |
| Clarus Therapeutics INC. | $38.84 | 2021 | |
| Allergan, INC. | $37.84 | 2019 | |
| Civco Medical Instruments | $36.12 | 2024 | |
| Laborie Medical Technologies Corp. | $34.86 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sagent Pharmaceuticals | $34.35 | 2019-2021 | |
| Axonics, INC. | $32.30 | 2024 | Axonics, Bulkamid |
| Medtronic, INC. | $29.70 | 2025 | Interstim |
| Rochester Medical Corporation | $24.54 | 2020 | |
| Edap Technomed INC | $24.00 | 2024 | |
| Amgen INC. | $23.27 | 2021 | |
| Integra Lifesciences Corporation | $20.85 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Tolmar Pharmaceuticals, INC. | $19.72 | 2019 | |
| Acerus Pharmaceuticals Corporation | $18.90 | 2022 | |
| Neotract INC. | $18.68 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.45 | 2021 | |
| Aytu Biopharma, INC. | $16.69 | 2020 | |
| Mckesson Patient Care Solutions INC. | $15.98 | 2019 | |
| Abc Home Medical Supply, INC. | $14.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Grotas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.